Pattern of failure after hepatic arterial concurrent chemoradiotherapy for locally advanced hepatocellular carcinoma. Background: There are limited modalities in the treatment of inoperable liver NET ...
HALIFAX, NS, April 8, 2026 /PRNewswire/ - ABK Biomedical, Inc. and COR Development are proud to announce a strategic partnership to develop a state-of-the-art GMP manufacturing facility in Cartwright ...
China has potentially revolutionized cancer therapy by producing Yttrium-90, a powerful beta-emitting isotope used to target liver tumors, using a commercial heavy-water reactor at the Qinshan Nuclear ...
KENNEWICK, Wash., Oct. 7, 2010 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation, ("AMIC") (OTCQB:ADMD), a company engaged in the production and distribution of medical isotopes, is delighted ...
Validation study of a prognostic classification system in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy. Background: Prospective evaluation of the ...
TAMPA, Fla. (March 16, 2010)—An interventional radiology treatment—the use of intra-arterial yttrium-90 microspheres for liver cancer (also known as hepatocellular carcinoma)—shows promise in ...
(RTTNews) - Boston Scientific Corp. (BSX) said that late-breaking data demonstrated improved progression-free survival in patients with metastatic colorectal cancer after treatment with boston ...
Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that one of the acquisition companies of the ...
The University Hospital at the University of Navarra is the only centre throughout the entire Spanish state for the treatment of liver tumours by means of radioembolisation and the one with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results